Literature DB >> 15018161

Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report.

L S Freudenberg1, G Antoch, R Görges, J Knust, R Pink, W Jentzen, J F Debatin, W Brandau, A Bockisch, J Stattaus.   

Abstract

Iodine-124 positron emission tomography (PET) is a useful 3D imaging technique for diagnosis and management of thyroid diseases. The difficulty in interpretation of the PET scans with highly selective tracers, such as iodine-124, is the lack of identifiable anatomical structures, so an accurate anatomical localization of foci presenting abnormal uptake is problematic. Consequently, a combined PET/CT scanner can resolve these difficulties by co-registering PET and CT data in a single session allowing a correlation of functional and morphologic imaging. A case is presented where iodine-124 produced by a clinical cyclotron and FDG were used to acquire images with a combined PET/CT scanner for clinical staging. On the basis of the PET/CT exams the treatment of the patient was modified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15018161     DOI: 10.1007/s00330-003-1884-x

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  23 in total

1.  Multiple papillary thyroid carcinoma metastases revealed on position emission tomography scan in a patient with negative 131I scan.

Authors:  J I Mechanick; C K Kim; B R Krynyckyi; J Machac; M L Urken
Journal:  Thyroid       Date:  2000-10       Impact factor: 6.568

2.  Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma.

Authors:  S M Bakheet; J E Powe; M M Hammami; M Ahmed
Journal:  Clin Nucl Med       Date:  1997-06       Impact factor: 7.794

3.  Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma.

Authors:  A Frilling; K Tecklenborg; R Görges; F Weber; M Clausen; E C Broelsch
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

4.  Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer.

Authors:  L Hooft; O S Hoekstra; W Devillé; P Lips; G J Teule; M Boers; M W van Tulder
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

5.  Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma.

Authors:  A Frilling; R Görges; K Tecklenborg; P Gassmann; M Bockhorn; M Clausen; C E Broelsch
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

6.  Prognostic value of [18F]fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer.

Authors:  W Wang; S M Larson; M Fazzari; S K Tickoo; K Kolbert; G Sgouros; H Yeung; H Macapinlac; J Rosai; R J Robbins
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

7.  Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy.

Authors:  B O Helal; P Merlet; M E Toubert; B Franc; C Schvartz; H Gauthier-Koelesnikov; A Prigent; A Syrota
Journal:  J Nucl Med       Date:  2001-10       Impact factor: 10.057

8.  Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.

Authors:  Susanne M Eschmann; Gerald Reischl; Kilian Bilger; Juergen Kupferschläger; Marcel H Thelen; Bernhard M Dohmen; Hariolf Besenfelder; Roland Bares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-27       Impact factor: 9.236

9.  Investigational study of iodine-124 with a positron camera.

Authors:  R M Lambrecht; N Woodhouse; R Phillips; D Wolczak; A Qureshi; E D Reyes; C Graser; S Al-Yanbawi; A Al-Rabiah; W Meyer
Journal:  Am J Physiol Imaging       Date:  1988

10.  In vivo imaging of the human thyroid with a positron camera using 124I.

Authors:  P Frey; D Townsend; A Jeavons; A Donath
Journal:  Eur J Nucl Med       Date:  1985
View more
  9 in total

1.  [Principles of PET/CT and clinical application].

Authors:  A Bockisch; T Beyer; G Antoch; P Veit; S Müller; R Pink; S Rosenbaum; H Kühl
Journal:  Radiologe       Date:  2004-11       Impact factor: 0.635

2.  Location of functioning metastases from differentiated thyroid carcinoma by simultaneous double isotope acquisition of I-131 whole body scan and bone scan.

Authors:  C Ceccarelli; F Bianchi; D Trippi; F Brozzi; F Di Martino; P Santini; R Elisei; A Pinchera
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

3.  Workshop on the production, application and clinical translation of ''non-standard'' PET nuclides: a meeting report.

Authors:  J S Lewis; M J Welch; L Tang
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-11-28       Impact factor: 2.346

4.  Combined metabolic and morphologic imaging in thyroid carcinoma patients with elevated serum thyroglobulin and negative cervical ultrasonography: role of 124I-PET/CT and FDG-PET.

Authors:  L S Freudenberg; G Antoch; A Frilling; W Jentzen; S J Rosenbaum; H Kühl; A Bockisch; R Görges
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-12       Impact factor: 9.236

5.  Lobar mucinous bronchioloalveolar carcinoma of the lung showing negative FDG uptake on integrated PET/CT.

Authors:  Yon Mi Sung; Kyung Soo Lee; Byung-Tae Kim; Joungho Han; Eun Jeong Lee
Journal:  Eur Radiol       Date:  2005-02-17       Impact factor: 5.315

6.  Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET.

Authors:  Chang-Lae Lee; Hilla Wahnishe; George A Sayre; Hyo-Min Cho; Hee-Joung Kim; Miguel Hernandez-Pampaloni; Randall A Hawkins; Shorouk F Dannoon; Henry F VanBrocklin; Melissa Itsara; William A Weiss; Xiaodong Yang; Daphne A Haas-Kogan; Katherine K Matthay; Youngho Seo
Journal:  Med Phys       Date:  2010-09       Impact factor: 4.071

7.  Value of (124)I-PET/CT in staging of patients with differentiated thyroid cancer.

Authors:  L S Freudenberg; G Antoch; W Jentzen; R Pink; J Knust; R Görges; S P Müller; A Bockisch; J F Debatin; W Brandau
Journal:  Eur Radiol       Date:  2004-06-30       Impact factor: 5.315

8.  The Combination of In vivo (124)I-PET and CT Small Animal Imaging for Evaluation of Thyroid Physiology and Dosimetry.

Authors:  Henrik H El-Ali; Martin Eckerwall; Dorthe Skovgaard; Erik Larsson; Sven-Erik Strand; Andreas Kjaer
Journal:  Diagnostics (Basel)       Date:  2012-06-05

9.  The diagnostic value of 124I-PET in patients with differentiated thyroid cancer.

Authors:  Ha T T Phan; Pieter L Jager; Anne M J Paans; John T M Plukker; M G G Sturkenboom; W J Sluiter; Bruce H R Wolffenbuttel; Rudi A J O Dierckx; Thera P Links
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-04       Impact factor: 9.236

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.